Pharmacolog appoints Chief Operating Officer
Pharmacolog appoints Lars Gusch as Chief Operating Officer (COO). Lars has extensive experience of organizational development in service and supply chain management and will join on January 1st, 2022. Lars most recently came from Coala Life AB, where he had the role of Technical Product Owner.
As COO, Lars will primarily be responsible for developing Pharmacolog’s service offering and structuring the service operations. Furthermore, Lars will have the overall responsibility for supply chain management. Lars' previous experience includes positions at BrainLAB AG, Nucletron AB and Elekta AB, including Manager of Engineering and global service manager. Lars has previously worked at Pharmacolog 2019 - 2020 as Development Manager and has a Master's Degree from the Technical University of Ilmenau, Germany.
CEO Mats Högberg comments. “We are very happy that Lars has chosen to accept the role of COO. As we had a significant increase in the number of installations during the year and saw increased demand, it is of great importance that we ensure our capability to deliver a high level of service to our customers. The technology platform we have developed gives us the opportunity to remotely both maintain our products and offer advanced additional services. In addition, Lars will lead the work of ensuring the expansion and development of our production capacity to handle future volumes in a cost-effective way. Lars, with his many years of experience from similar tasks, will be a much appreciated and valuable."
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products, DrugLog®, WasteLog® and PrepLog®, help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion. The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
